Literature DB >> 3350277

Experimental immunological intrahepatic cholestasis model.

Y Mizoguchi1, Y Sakagami, K Miyajima, S Yamamoto, S Morisawa.   

Abstract

Heat-killed Propionibacterium acnes (P. acnes) was intravenously injected into tuberculin-sensitized guinea pigs, and 7 days later, purified protein derivative (PPD) was also injected intravenously resulting in marked reductions in bile flow and bile acid excretion. Serum levels of bile acids and cholesterol were increased, and the activities of alkaline phosphatase (ALK-p) and leucine aminopeptidase (LAP) were also elevated. Histological examination revealed dilatation of bile canaliculi and diminution of microvilli. These results indicated that intrahepatic cholestasis was induced. These pathological changes were not detected in guinea pigs in which PPD was not injected. In this experimental model, the tuberculin-sensitized lymphocytes were infiltrated into the liver by P. acnes injection and the cholestatic factor was produced by PPD injection, resulting in the induction of intrahepatic cholestasis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3350277     DOI: 10.1007/bf02918851

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  16 in total

1.  MEASUREMENT OF HUMAN SERUM BILE ACIDS BY GAS-LIQUID CHROMATOGRAPHY.

Authors:  D H SANDBERG; J SJOEVALL; K SJOEVALL; D A TURNER
Journal:  J Lipid Res       Date:  1965-04       Impact factor: 5.922

2.  The colorimetric determination of leucine aminopeptidase in urine and serum of normal subjects and patients with cancer and other diseases.

Authors:  J A GOLDBARG; A M RUTENBURG
Journal:  Cancer       Date:  1958 Mar-Apr       Impact factor: 6.860

3.  Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine.

Authors:  P R KIND; E J KING
Journal:  J Clin Pathol       Date:  1954-11       Impact factor: 3.411

4.  Optimization of methods for aspartate aminotransferase and alanine aminotransferase.

Authors:  H U Bergmeyer; P Scheibe; A W Wahlefeld
Journal:  Clin Chem       Date:  1978-01       Impact factor: 8.327

5.  Modulation of cholestatic factor production by serum components.

Authors:  Y Mizoguchi; Y Sakagami; H Sawai; H Tsutsui; T Monna; S Yamamoto; S Morisawa
Journal:  Gastroenterol Jpn       Date:  1983-08

6.  Participation of cholestatic factor in the pathogenesis of intrahepatic cholestasis in acute viral hepatitis.

Authors:  Y Mizoguchi; Y Sakagami; H Tsutsui; T Monna; S Yamamoto; S Morisawa
Journal:  Arerugi       Date:  1983-04

7.  [Studies on the action mechanism of cholestatic factor: effects on the bile acid--dependent and independent bile flow and erythritol clearance].

Authors:  Y Sakagami; K Miyajima; H Tsutsui; T Shiba; T Higashimori; M Nakao; Y Mizoguchi; T Monna; S Yamamoto; S Morisawa
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1982-11

8.  Detection of the cholestatic factor in the liver tissue of patients with acute intrahepatic cholestasis.

Authors:  Y Mizoguchi; K Miyajima; Y Sakagami; S Yamamoto; S Morisawa
Journal:  Ann Allergy       Date:  1986-04

9.  Participation of the cholestatic factor in the pathogenesis of intrahepatic cholestasis, found in various liver diseases.

Authors:  Y Mizoguchi; Y Sakagami; T Monna; S Yamamoto; S Morisawa
Journal:  Gastroenterol Jpn       Date:  1982

10.  Partial purification of the cholestatic factor derived from the lymphocytes of tuberculin-sensitized guinea pigs.

Authors:  Y Mizoguchi; F Ohnishi; T Monna; S Yamamoto; S Morisawa
Journal:  Gastroenterol Jpn       Date:  1981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.